文献速递心脑血管急症复苏、休克与脓毒症

长距离跑步比赛中的心脏骤停

Cardiac Arrest During Long-Distance Running Races.
PubMed 文献 · JAMA · 2025-01-01
一句话结论2010-2023年美国马拉松与半程马拉松中,心脏骤停发生率保持稳定,但心脏性死亡发生率和病例致死率显著下降,冠状动脉疾病是最常见病因。

该观察性病例系列来自Race Associated Cardiac Event Registry,纳入2010年1月1日至2023年12月31日美国马拉松和半程马拉松跑者,共29 311 597名完赛者中发生176例心脏骤停。与2000-2009年相比,心脏骤停发生率无变化(0.54/10万 vs 0.60/10万),但心脏性死亡发生率(0.20/10万 vs 0.39/10万)和病例致死率(34% vs 71%)显著下降。在可确定病因的67/128例(52%)中,冠状动脉疾病而非肥厚型心肌病是最常见病因。缩短心肺复苏时间和初始室性快速性心律失常心律与生存相关。作者认为,有效的应急行动计划与即时除颤可能解释了生存改善。

要点

  • 2010-2023年美国长距离跑步比赛心脏骤停发生率为0.54/10万(95%CI 0.41-0.70),与2000-2009年的0.60/10万(95%CI 0.52-0.70)相比无变化。
  • 心脏性死亡发生率从2000-2009年的0.39/10万(95%CI 0.28-0.52)降至2010-2023年的0.20/10万(95%CI 0.15-0.26),病例致死率从71%降至34%。
  • 男性心脏骤停发生率(1.12/10万,95%CI 0.95-1.32)高于女性(0.19/10万,95%CI 0.13-0.27);马拉松(1.04/10万,95%CI 0.82-1.32)高于半程马拉松(0.47/10万,95%CI 0.38-0.57)。
  • 在可确定病因的67/128例(52%)中,冠状动脉疾病是最常见病因,而非肥厚型心肌病。
  • 缩短心肺复苏时间和初始室性快速性心律失常心律与生存相关;作者认为有效应急行动计划与即时除颤可能解释生存改善。

适用人群与场景

  • 2010年1月1日至2023年12月31日美国马拉松和半程马拉松完赛跑者,共29 311 597名完赛者。
  • 娱乐性长距离跑步(马拉松和半程马拉松距离)参与者。

红旗征与不能漏的情况

  • 长距离跑步比赛中发生心脏骤停需立即识别并启动应急反应,缩短心肺复苏时间与生存相关。
  • 初始心律为室性快速性心律失常与生存相关。
  • 作者认为有效应急行动计划与即时除颤可能解释生存改善。

研究设计与关键结果

  • 研究类型:观察性病例系列,数据来自Race Associated Cardiac Event Registry,队列数据为2010年1月1日至2023年12月31日美国马拉松和半程马拉松跑者。
  • 共29 311 597名完赛者中发生176例心脏骤停(127名男性、19名女性、30名性别未知)。
  • 心脏骤停发生率与2000-2009年相比无变化:0.54/10万(95%CI 0.41-0.70) vs 0.60/10万(95%CI 0.52-0.70)。
  • 心脏性死亡发生率显著下降:0.20/10万(95%CI 0.15-0.26) vs 0.39/10万(95%CI 0.28-0.52);病例致死率34% vs 71%。
  • 男性心脏骤停发生率1.12/10万(95%CI 0.95-1.32),女性0.19/10万(95%CI 0.13-0.27);马拉松1.04/10万(95%CI 0.82-1.32),半程马拉松0.47/10万(95%CI 0.38-0.57)。
  • 在可确定病因的67/128例(52%)中,冠状动脉疾病是最常见病因,而非肥厚型心肌病。
  • 缩短心肺复苏时间和初始室性快速性心律失常心律与生存相关。

证据类型、等级与局限

  • 证据类型:观察性病例系列。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,有效的应急行动计划与即时除颤可能解释生存改善。
  • 缩短心肺复苏时间与生存相关,提示比赛中快速启动心肺复苏的重要性。
  • 初始室性快速性心律失常心律与生存相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: More than 29 million participants completed marathons and half-marathons in the US between 2010-2023, approximately 3 times the number from 2000-2009. Contemporary long-distance race-related cardiac arrest incidence and outcomes are unknown.

OBJECTIVE: To determine the incidence and outcomes of cardiac arrests during US marathons and half-marathons between 2010-2023 from a record of race finishers and a comprehensive review of cases from media reports, direct contact with race directors, USA Track & Field claims, and interviews with survivors or next of kin.

DESIGN, SETTING, AND PARTICIPANTS: Observational case series from the Race Associated Cardiac Event Registry; cohort data from US marathon and half-marathon runners from January 1, 2010, to December 31, 2023. Case profiles were reviewed to determine etiology and factors associated with survival. Incidence and etiology data were compared with historical reference standards (2000-2009).

EXPOSURE: Recreational long-distance running (marathon and half-marathon distance).

MAIN OUTCOMES: Incidence proportions of sudden cardiac arrest and death.

RESULTS: Among 29 311 597 race finishers, 176 cardiac arrests (127 men, 19 women, 30 sex unknown) occurred during US long-distance running races. Compared with 2000-2009, cardiac arrest incidence remained unchanged (incidence rate, 0.54 per 100 000 participants [95% CI, 0.41-0.70] vs 0.60 per 100 000 [95% CI, 0.52-0.70], respectively). However, there were significant declines in cardiac death incidence (0.20 per 100 000 [95% CI, 0.15-0.26] vs 0.39 per 100 000 [95% CI, 0.28-0.52]) and case fatality rate (34% vs 71%). Cardiac arrests remained more common among men (1.12 per 100 000 [95% CI, 0.95-1.32]) than women (0.19 per 100 000 [95% CI, 0.13-0.27]) and during the marathon (1.04 per 100 000 [95% CI, 0.82-1.32]), compared with the half-marathon (0.47 per 100 000 [95% CI, 0.38-0.57]). Among runners for which a definitive cause of cardiac arrest could be determined (n = 67/128 [52%]), coronary artery disease rather than hypertrophic cardiomyopathy was the most common etiology. Decreased cardiopulmonary resuscitation time and an initial ventricular tachyarrhythmia rhythm were associated with survival.

CONCLUSIONS AND RELEVANCE: Despite increased participation in US long distance running races, cardiac arrest incidence remains stable. There has been a marked decline in cardiac arrest mortality, and coronary artery disease was the most common etiology among cases with sufficient cause-related data. Effective emergency action planning with immediate access to defibrillation may explain the improvement in survival.

来源:JAMA,查看原文。版权归原作者所有。

参考来源

  1. Kim JH, Rim AJ, Miller JT, et al. Cardiac Arrest During Long-Distance Running Races. JAMA. 2025. PMID: 40159341. doi:10.1001/jama.2025.3026

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。